GLP-1 Options for Weight Loss & Diabetes

Last reviewed: May 15, 2026

Last updated: May 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 receptor agonists have transformed diabetes and weight management treatment since their introduction, with clinical trials demonstrating average weight loss of 15-22% depending on the specific medication and dose. Beyond understanding brand names, it's important to evaluate how these medications work, what evidence supports their use, and how individual biomarkers and genetic factors may relate to treatment outcomes.

Choosing the right medication involves more than comparing brand availability. A precision-wellness approach considers your metabolic profile, genetic predispositions in peptide pathways, and clinical history to support a more informed conversation with your healthcare provider about which medication may align with your health goals.

How GLP-1 Medications Work: Mechanism and Clinical Evidence

GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone that regulates blood sugar and appetite. These medications enhance insulin secretion when glucose levels are high, slow gastric emptying, and promote satiety signaling in the brain. Clinical trials across multiple medications show consistent benefits for glycemic control and weight reduction.

The mechanism explains why these drugs benefit both diabetes management and weight loss. Studies show improvements in HbA1c levels ranging from 1-2%, alongside cardiovascular risk reduction in patients with existing heart disease. Understanding this shared mechanism helps explain why similar medications produce comparable metabolic benefits.

Medication Classes and Formulation Options: Key Differences

GLP-1 medications come in different formulations—injectable weekly, injectable daily, and oral daily options—each with distinct pharmacokinetics and dosing schedules. Additionally, newer medications combine GLP-1 with GIP receptor agonism, offering a dual mechanism that may enhance weight loss and glycemic control compared to single-agent GLP-1 therapy alone.

Medication Class	Formulation Type	Typical Dosing	Primary Mechanism
GLP-1 RA (single agent)	Injectable weekly	Once weekly	GLP-1 receptor activation
GLP-1 RA (single agent)	Oral daily	Once daily	GLP-1 receptor activation
GLP-1 RA (single agent)	Injectable daily	Once or twice daily	GLP-1 receptor activation
GLP-1/GIP RA (dual agent)	Injectable weekly	Once weekly	Dual GLP-1 and GIP receptor activation

Evaluating Treatment Response: Biomarkers and Early Indicators

Treatment response varies significantly between individuals, with some patients experiencing rapid weight loss and blood sugar improvement while others progress more gradually. Early biomarkers—including fasting glucose, HbA1c, lipid panels, and inflammatory markers like CRP—help your provider assess whether a medication is working as expected after 8-12 weeks of consistent use.

Genetic factors in your GLP-1 receptor gene, FTO gene variants, and MC4R pathway may provide context for understanding individual variation in appetite suppression and metabolic response. PlexusDx's Precision Peptide Genetic Test identifies predispositions in these pathways, which can support a more informed conversation with your provider about whether your current medication aligns with your genetic profile.

Safety Considerations and Who Should Consider These Medications

GLP-1 medications are well-tolerated overall, with the most common side effects being gastrointestinal—nausea, vomiting, diarrhea, and constipation—that typically decrease after the first few weeks. However, these medications are not suitable for individuals with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe pancreatitis, and require careful monitoring in those with diabetic retinopathy.

Treatment selection should involve your healthcare provider's assessment of your complete medical history, current medications, kidney function, and cardiovascular risk. Those with established cardiovascular disease may benefit particularly from certain GLP-1 agents shown to reduce major adverse cardiac events. Your provider should evaluate contraindications and monitor for side effects throughout treatment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in key genes that influence GLP-1 signaling and metabolic regulation—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants may help provide context for understanding individual differences in appetite regulation and weight loss trajectory, supporting a more personalized conversation with your healthcare provider.

The genetic test does not predict exact medication response or guarantee outcomes. Rather, it identifies your genetic predispositions across peptide-signaling pathways, which can be one data point among many—including biomarkers, medical history, and clinical response—that your provider considers when evaluating medication fit.

Understanding your genetic predispositions in these pathways may help explain why you respond to treatment differently than others, and can support more informed discussions about dosing adjustments, formulation selection, or whether combination therapy might be appropriate for your health goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the most affordable GLP-1 option for glp-1 options for weight loss & diabetes?

PlexusDx offers compounded semaglutide starting at $149/mo and a Microdose GLP-1 Protocol from $129/month — both from licensed 503A compounding pharmacies, with no membership fee.

Does PlexusDx serve patients in all 50 states?

Yes. PlexusDx serves all 50 states. Five states require a scheduled live video consultation before the first prescription is issued; all others use async intake.

How does genetic testing improve GLP-1 outcomes?

Variants like GIPR rs1800437 affect GIP receptor function and predict differential response to tirzepatide versus semaglutide. PlexusDx's Precision Peptide Genetic Test evaluates 150+ relevant variants to guide medication selection.

Is compounded semaglutide the same as Wegovy or Ozempic?

Compounded semaglutide uses the same active ingredient but is not FDA-approved. It is prepared under federal compounding regulations at licensed 503A compounding pharmacies.

Can I use HSA or FSA funds to pay for PlexusDx?

Yes. Prescription GLP-1 medications from PlexusDx are HSA/FSA eligible with a valid prescription. PlexusDx accepts HSA and FSA cards directly at checkout.

GLP-1 Options for Weight Loss & Diabetes | PlexusDx